During the past decade, NSABP Foundation, Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NSABP Foundation, Inc" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "International Drug Development Institute" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "NSABP Foundation, Inc" are "Breast Cancer" (9 trials), "CPS-EG Score" (1 trials), "HER2-negative Breast Cancer" (1 trials), "Her2-normal" (1 trials) and "Hormonreceptor Positive" (1 trials). Many other conditions were trialed in "NSABP Foundation, Inc" in a lesser frequency.

Most popular intervention types in "NSABP Foundation, Inc" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (5 trials), "Bevacizumab" (3 trials), "Docetaxel" (3 trials), "Doxorubicin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "NSABP Foundation, Inc" are 9 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "NSABP Foundation, Inc". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in NSABP Foundation, Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NSABP Foundation, Inc, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".